ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,465.99
-0.06%
Dow Jones
39,141.07
0.07%
US Dollar vs MXN
18.29593
0.94%
Brent Oil
85.025
1.00%
Bitcoin
60,969.66
-1.38%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Simulations Plus Inc (SLP)

  7. Simulations Plus Inc (SLP) Noticias

SLP

Simulations Plus (SLP)

Simulations Plus Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SLP
FechaHoraFuenteTítuloSímboloCompañía
20/06/202407:30Business WireSimulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI SummitNASDAQ:SLPSimulations Plus Inc
18/06/202407:30Business WireSimulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call DateNASDAQ:SLPSimulations Plus Inc
12/06/202407:58Business WireQHP Capital-Backed Pro-ficiency Acquired by Simulations PlusNASDAQ:SLPSimulations Plus Inc
12/06/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLPSimulations Plus Inc
12/06/202407:00Business WireSimulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development ContinuumNASDAQ:SLPSimulations Plus Inc
04/06/202416:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLPSimulations Plus Inc
03/06/202415:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SLPSimulations Plus Inc
22/05/202407:30Business WireSimulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor ConferenceNASDAQ:SLPSimulations Plus Inc
15/05/202407:30Business WireSimulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation SoftwareNASDAQ:SLPSimulations Plus Inc
04/04/202407:30Business WireU.S. FDA Renews DILIsym® Software Licenses for 7th YearNASDAQ:SLPSimulations Plus Inc
04/04/202406:30IH Market NewsExxon Mobil Forecasts Earnings Decline, Twilio Seeks Board Tenure Changes, and More NewsNASDAQ:SLPSimulations Plus Inc
03/04/202415:34Business WireSimulations Plus Reports Second Quarter Fiscal 2024 Financial ResultsNASDAQ:SLPSimulations Plus Inc
03/04/202406:11IH Market NewsU.S. Futures Dip in Pre-Market, May WTI and June Brent Crude Prices Edge HigherNASDAQ:SLPSimulations Plus Inc
20/03/202415:06Business WireSimulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call DateNASDAQ:SLPSimulations Plus Inc
13/03/202407:30Business WireSimulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor ForumNASDAQ:SLPSimulations Plus Inc
06/03/202415:07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SLPSimulations Plus Inc
05/03/202407:30Business WireSimulations Plus and the University of Bath Awarded New FDA GrantNASDAQ:SLPSimulations Plus Inc
15/02/202407:30Business WireSimulations Plus Extends Collaboration with Major Toxicology Research AgencyNASDAQ:SLPSimulations Plus Inc
13/02/202408:15Business WireSimulations Plus Launches Corporate Development InitiativeNASDAQ:SLPSimulations Plus Inc
12/02/202415:59Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SLPSimulations Plus Inc
06/02/202407:30Business WireSimulations Plus to Participate in Upcoming Healthcare ConferencesNASDAQ:SLPSimulations Plus Inc
30/01/202407:30Business WireSimulations Plus Releases GastroPlus® Version 9.9NASDAQ:SLPSimulations Plus Inc
12/01/202416:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SLPSimulations Plus Inc
09/01/202407:30Business WireSimulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA GrantNASDAQ:SLPSimulations Plus Inc
05/01/202406:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLPSimulations Plus Inc
03/01/202415:06Business WireSimulations Plus Reports First Quarter Fiscal 2024 Financial ResultsNASDAQ:SLPSimulations Plus Inc
03/01/202415:05Business WireSimulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving GrowthNASDAQ:SLPSimulations Plus Inc
26/12/202318:54Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SLPSimulations Plus Inc
22/12/202307:40Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SLPSimulations Plus Inc
22/12/202306:43Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SLPSimulations Plus Inc
 Showing the most relevant articles for your search:NASDAQ:SLP

Su Consulta Reciente

NASDAQ
CDTTW
Conduit Pharmaceuticals
BIT
UC72MM
Unicredit Bank
TSXV
LEA
LSE
DY64
5% 2025p
KUCN
DACCBTC
Decentralized Accessible Content
ASX
CTMR
BMF
DIIN24V26
DIIN24V26 - 07/2024
LSE
52BM
Int.fin. 46
TG
A19U5P
Gas Natural Fenosa Finan...
TG
A28VK9
Aeroports de Paris
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados